|
1.
What is your primary practice?
N=115
2.
Where are you from?
N=123
3.
If you are from the US, in which region of the
country do
N=67
you
practice?
4.
Who is performing atrial fibrillation procedures at
your hospital?
N=108
5.
How many surgical or interventional procedures do
you perform per N=106
YEAR
to treat atrial fibrillation?
6.
Does your institution currently perform catheter
ablations for AF?
N=119
7.
Based on your personal experience, word of mouth,
and research to
N=119
date, do you think catheter ablation
is:
8.
How many Cox-MAZE procedures do you currently
perform per YEAR N=108
for AF?
9.
If you do not perform the Cox-MAZE procedure in
patients coming to
N=91
cardiac
surgery with concomitant AF, why not?
10.
Do you currently perform the radial procedure?
N=121
11.
What percent of your heart valve patients have
chronic AF?
N=124
12.
What percentage of patients with chronic AF
indicated for mitral valve
N=119
replacement/repair do you
perform concomitant AF surgery?
13.
What percentage of patients indicated for mitral
valve replacement/
N=115
repair,
would you treat for AF if you
had a simpler, quicker procedure?
14.
Which of the following advances do you consider
MOST important to
N=111
increase
your number of surgical procedures for the treatment of AF?
15.
Have you used ablation devices to treat AF in the
last year?
N=121
16.
If you have used an ablation device, what was the
energy source?
N=85
17.
In your opinion, which ONE of the following
treatments for AF will see N=85
the
MOST growth over the next 3 to
5 years?
18.
What percent of your chronic AF patients have
paroxsysmal AF?
N=60
19.
Do you anticipate the number of surgical AF
procedures you
will
N=89
perform in 2003 to…
20.
What is an acceptable success rate for an OPEN
SURGICAL procedure
N=102
designed
to treat lone AF?
21.
What is an acceptable success rate for an
ENDOSCOPIC procedure
N=110
designed
to treat lone AF?
22.
What was the single most important
information/experience you
N=89
required before employing an ablation
device?
23.
What would you consider an acceptable success rate
for a simpler
N=77
procedure used to treat AF in
patients indicated for mitral valve
surgery?
24.
If a device were available to treat AF in patients
undergoing CABG and N=79
mitral
valve replacement/repair and was clinically effective, how much
would you
pay for it?
The following question was asked before and after a debate on laser
energy
25.
In your opinion, which of the following energy
sources for treating AF
will see
the MOST growth over the next 3 to 5 years?
Before debate: N=76
After debate: N=26
© 2002, Medtech Insight, LLC
|
